ARID1A and neoplasm: In this study, deep targeted sequencing was employed to examine the variance in mutation frequency of the ARID1A gene between primary glioblastoma and non‐glioblastoma, utilizing mismatch repair genes and tumor‐frequent mutation genes as benchmarks.